Visiongain Publishes Translational Regenerative Medicine Market Report 2024-2034

The global Translational Regenerative Medicine market is estimated at US$77.93 billion in 2024 and is expected to register a CAGR of 24.3% from 2024 to 2034.

Visiongain Publishes Epilepsy Therapeutics Market Report 2024-2034

The global Epilepsy Therapeutics market is estimated at US$9,858.7 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period 2024-2034.

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2024-2034

The global Companion Diagnostics (CDx) market is estimated at US$6,574.6 million in 2024 and is projected to grow at a CAGR of 11% during the forecast period 2024-2034.

Neuromodulation Devices Market Report 2024-2034, Overview of Visiongain’s 251 page report.

The global Neuromodulation Devices market is estimated at US$10,002.7 million in 2024 and is expected to register a CAGR of 12.4% from 2024 to 2034.

Visiongain Publishes Respiratory Drug Delivery Market Report 2024-2034

The global Respiratory Drug Delivery market is estimated at US$67.11 billion in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period 2024-2034.

Visiongain Publishes Pharmaceutical Logistics Market Report 2024-2034

The global Pharmaceutical Logistics Market is estimated at US$93.3 billion in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period 2024-2034.

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2024-2034

The precision cancer diagnostic test market was valued at US$10,623.3 million in 2023 and is projected to grow at a CAGR of 16.1% during the forecast period 2024-2034.

Antibacterial Drugs Market Report 2024-2034

The Antibacterial Drug market was valued at US$ 39,178.7 million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period 2024-2034.

Visiongain Publishes Pharma Clinical Trial Services Market Report 2024-2034

The global Pharma Clinical Trial Services market was valued at US$40.91 billion in 2023 and is projected to grow at a CAGR of 8.6% during the forecast period 2024-2034.

Visiongain Publishes Cell-Based Assays Market Report 2024-2034

The global Cell-Based Assays market is estimated at US$18,875.2 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.

Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034

The global Viral Vectors and Plasmid DNA Manufacturing market is estimated at US$1,168.9 million in 2023 and is projected to grow at a CAGR of 17.5% during the forecast period 2024-2034.

Visiongain Publishes Biological Drug API Manufacturing Services Market Report 2023-2033

The global Biological Drug API Manufacturing Services market is valued at US$8,006.7 million in 2023 and is projected to grow at a CAGR of 11.6% during the forecast period 2023-2033.

Visiongain Publishes Bioprocess Validation Market Report 2023-2033

The global Bioprocess Validation market is estimated at US$498.5 million in 2023 and is projected to grow at a CAGR of 10.8% during the forecast period 2023-2033.

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2024-2034

The global OTC Drugs & Dietary Supplements market was valued at US$ 211.8 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

Visiongain Publishes Biologics Market Report 2024-2034

The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

Visiongain Publishes mRNA Vaccines Market Report 2023-2033

The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.

Visiongain Publishes Stem Cell Technologies and Applications Market Report 2023-2033

The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.

Visiongain Publishes Neurology Clinical Trials Market Report 2023-2033

The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.

Visiongain Publishes Pharma Contract Sales Market Report 2023-2033

The global Pharma Contract Sales market is valued at US$7,678.6 million in 2023 and is projected to grow at a CAGR of 8.2% during the forecast period 2023-2033.

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034

The global Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs market is valued at US$24.2 billion in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period 2024-2034.

Clients & Partners